• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA NEAT1 通过调节非酒精性脂肪性肝病中的 miR-146a-5p/ROCK1 促进肝脂质积累。

LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.

机构信息

Department of Pediatrics, The Second Xiangya Hospital, Central South Univeristy, Changsha 410011, Hunan Province, PR China.

Department of Pediatrics, The Second Xiangya Hospital, Central South Univeristy, Changsha 410011, Hunan Province, PR China.

出版信息

Life Sci. 2019 Oct 15;235:116829. doi: 10.1016/j.lfs.2019.116829. Epub 2019 Sep 1.

DOI:10.1016/j.lfs.2019.116829
PMID:31484042
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the specific mechanism of the disease remains unknown, and effective treatments are still lacking. It was reported that Nuclear enriched abundant transcript 1 (NEAT1) obviously was up-regulated in NAFLD model. But the role and underlying mechanism of NEAT1 in NAFLD is unclear.

METHODS

HepG2 cells were treated by free fatty acids (FFA) and C57BL/6J mice were treated by high-fat diet to establish NAFLD in vitro and in vivo models, respectively. Cell transfection was applied to regulate the expression of NEAT1, ROCK1, and miR-146a-5p. Western blotting and qRT-PCR were used for measuring expression of protein and mRNA level, respectively. Dual luciferase assay was used to detect the target relationship. Oil Red O staining was used to measure the lipid accumulation. HE staining was used for observing pathological feature of liver tissues.

RESULTS

High levels of NEAT1 and ROCK1, and low level of miR-146a-5p were identified in NAFLD models. NEAT1 could target miR-146a-5p to promote ROCK1 expression. Knockdown of NEAT1, overexpression of miR-146a-5p and knockdown of ROCK1 inhibited lipid accumulation through activating AMPK pathway.

CONCLUSION

NEAT1 may regulate NAFLD through miR-146a-5p targeting ROCK1, and further affect AMPK/SREBP pathway. This study may provide a new thought for the treatment of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种严重的肝脏疾病,影响着全球人民的健康。然而,该病的确切机制尚不清楚,有效的治疗方法仍然缺乏。有报道称,核富集丰富转录本 1(NEAT1)在 NAFLD 模型中明显上调。但是,NEAT1 在 NAFLD 中的作用和潜在机制尚不清楚。

方法

用游离脂肪酸(FFA)处理 HepG2 细胞,用高脂肪饮食处理 C57BL/6J 小鼠,分别建立体外和体内 NAFLD 模型。应用细胞转染调节 NEAT1、ROCK1 和 miR-146a-5p 的表达。Western blot 和 qRT-PCR 分别用于测量蛋白和 mRNA 水平的表达。双荧光素酶报告基因检测用于检测靶标关系。油红 O 染色用于测量脂质积累。HE 染色用于观察肝组织的病理特征。

结果

在 NAFLD 模型中发现 NEAT1 和 ROCK1 水平升高,miR-146a-5p 水平降低。NEAT1 可以通过靶向 miR-146a-5p 来促进 ROCK1 的表达。敲低 NEAT1、过表达 miR-146a-5p 和敲低 ROCK1 通过激活 AMPK 通路抑制脂质积累。

结论

NEAT1 可能通过 miR-146a-5p 靶向 ROCK1 调节 NAFLD,并进一步影响 AMPK/SREBP 通路。这项研究为 NAFLD 的治疗提供了新的思路。

相似文献

1
LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease.长链非编码 RNA NEAT1 通过调节非酒精性脂肪性肝病中的 miR-146a-5p/ROCK1 促进肝脂质积累。
Life Sci. 2019 Oct 15;235:116829. doi: 10.1016/j.lfs.2019.116829. Epub 2019 Sep 1.
2
LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling.长链非编码 RNA NEAT1-微小 RNA-140 轴通过阻断 AMPK/SREBP-1 信号通路加重非酒精性脂肪性肝病。
Biochem Biophys Res Commun. 2019 Aug 20;516(2):584-590. doi: 10.1016/j.bbrc.2019.06.104. Epub 2019 Jun 22.
3
Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway.沉默长链非编码RNA NEAT1通过调控miR-139-5p/c-Jun/SREBP-1c信号通路减少非酒精性脂肪肝的脂肪沉积。
Ann Hepatol. 2022 Mar-Apr;27(2):100584. doi: 10.1016/j.aohep.2021.100584. Epub 2021 Nov 19.
4
Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.乙酰化的 H3K27 激活长链非编码 RNA NEAT1,并通过调节 miR-212-5p/GRIA3 促进非酒精性脂肪性肝病中的肝脂质积累。
Mol Cell Biochem. 2022 Jan;477(1):191-203. doi: 10.1007/s11010-021-04269-0. Epub 2021 Oct 15.
5
LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis.长链非编码RNA HOTAIR通过miR-130b-3p/ROCK1轴调控非酒精性脂肪性肝病中的脂质积累。
Cell Signal. 2022 Feb;90:110190. doi: 10.1016/j.cellsig.2021.110190. Epub 2021 Nov 11.
6
Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.环状 RNA 0057558 通过靶向 miR-206 调控 ROCK1/AMPK 信号通路促进非酒精性脂肪性肝病。
Cell Death Dis. 2021 Aug 26;12(9):809. doi: 10.1038/s41419-021-04090-z.
7
lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3.长链非编码 RNA NEAT1 通过调控 miR-506/GLI3 调节非酒精性脂肪性肝病引起的纤维化和炎症反应。
Eur Cytokine Netw. 2019 Sep 1;30(3):98-106. doi: 10.1684/ecn.2019.0432.
8
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.miR-122 通过靶向 Sirt1 抑制 LKB1/AMPK 通路促进非酒精性脂肪性肝病中的肝脂肪生成。
Mol Med. 2019 Jun 13;25(1):26. doi: 10.1186/s10020-019-0085-2.
9
Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.下调 microRNA-130b-5p 可预防非酒精性脂肪性肝病小鼠模型中的脂质积累和胰岛素抵抗。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E34-E42. doi: 10.1152/ajpendo.00528.2019. Epub 2020 Mar 31.
10
Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.长链非编码 RNA AC012668 通过与脂蛋白相关蛋白 LRP2 竞争 microRNA miR-380-5p 来抑制非酒精性脂肪性肝病。
Bioengineered. 2021 Dec;12(1):6738-6747. doi: 10.1080/21655979.2021.1960463.

引用本文的文献

1
Advances in the Regulation of Lipid Metabolism by Non-Coding RNAs.非编码RNA对脂质代谢调控的研究进展
Animals (Basel). 2025 Sep 7;15(17):2621. doi: 10.3390/ani15172621.
2
Engineered Hydrogels for Organoid Models of Human Nonalcoholic Fatty Liver Disease.用于人类非酒精性脂肪性肝病类器官模型的工程水凝胶
Adv Sci (Weinh). 2025 Jun;12(22):e17332. doi: 10.1002/advs.202417332. Epub 2025 May 14.
3
Construction of ceRNA networks of lncRNA and miRNA associated with intramuscular fat deposition in Ujumqin sheep.与乌珠穆沁羊肌内脂肪沉积相关的长链非编码RNA和微小RNA的ceRNA网络构建
Front Vet Sci. 2025 Mar 19;12:1559727. doi: 10.3389/fvets.2025.1559727. eCollection 2025.
4
Research on the function of epigenetic regulation in the inflammation of non-alcoholic fatty liver disease.非酒精性脂肪性肝病炎症中表观遗传调控功能的研究
Life Med. 2024 Aug 31;3(4):lnae030. doi: 10.1093/lifemedi/lnae030. eCollection 2024 Aug.
5
Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis.长链非编码RNA在代谢功能障碍相关脂肪性肝病和肝纤维化发病机制中的作用机制
eGastroenterology. 2024 Nov;2(4):e100115. doi: 10.1136/egastro-2024-100115. Epub 2024 Nov 18.
6
MiR-146a-5p-enriched exosomes inhibit M1 macrophage activation and inflammatory response by targeting CD80.富含 miR-146a-5p 的外泌体通过靶向 CD80 抑制 M1 巨噬细胞的激活和炎症反应。
Mol Biol Rep. 2024 Nov 8;51(1):1133. doi: 10.1007/s11033-024-10088-5.
7
Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?非酒精性脂肪性肝病中的长链非编码RNA:是友是敌?
Cell Biochem Biophys. 2025 Mar;83(1):279-294. doi: 10.1007/s12013-024-01555-8. Epub 2024 Oct 8.
8
Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism.长链非编码RNA ARSR在肿瘤增殖、耐药性以及脂质和胆固醇代谢中的作用。
Clin Transl Oncol. 2025 Apr;27(4):1356-1365. doi: 10.1007/s12094-024-03700-4. Epub 2024 Sep 9.
9
NEAT1 inhibits the angiogenic activity of cerebral arterial endothelial cells by inducing the M1 polarization of microglia through the AMPK signaling pathway.NEAT1 通过激活 AMPK 信号通路诱导小胶质细胞 M1 极化抑制脑动脉内皮细胞的血管生成活性。
Cell Mol Biol Lett. 2024 Apr 29;29(1):62. doi: 10.1186/s11658-024-00579-5.
10
Oligonucleotide therapies for nonalcoholic steatohepatitis.用于非酒精性脂肪性肝炎的寡核苷酸疗法。
Mol Ther Nucleic Acids. 2024 Mar 30;35(2):102184. doi: 10.1016/j.omtn.2024.102184. eCollection 2024 Jun 11.